adenine has been researched along with ristocetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, M; Drucker, C; Egle, A; Einberger, C; Follows, G; Hauswirth, A; Heinz, M; Hoermann, G; Jaeger, U; Jilma, B; Kazianka, L; Melchardt, T; Pabinger, I; Porpaczy, E; Quehenberger, P; Raderer, M; Skrabs, C; Staber, PB; Struve, S; Thalhammer, R; Thomas, W; Wendtner, CM | 1 |
| Alberelli, MA; Autore, F; De Candia, E; Innocenti, I; Laurenti, L | 1 |
2 other study(ies) available for adenine and ristocetin
| Article | Year |
|---|---|
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Drug Monitoring; Female; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Platelet Aggregation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ristocetin | 2017 |
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients.
Topics: Adenine; Aged; Aged, 80 and over; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Platelet Aggregation; Platelet Function Tests; Pyrazoles; Pyrimidines; Ristocetin | 2018 |